Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:
Agios Pharmaceuticals
AGIO
: is a biopharmaceutical company focused on development of treatments for rare genetic metabolic disorders, a subset of orphan genetic metabolic diseases. The Zacks Consensus Estimate for its current year earnings has been revised 26.6% downward over the last 60 days.
Alimera Sciences
ALIM
: is a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. The Zacks Consensus Estimate for its current year earnings has been revised 302.1% downward over the last 60 days.
BrightView (
BV
): is a provider of commercial landscaping services primarily in the United States. The Zacks Consensus Estimate for its current year earnings has been revised almost 7.4% downward over the last 60 days.
View the entire
Zacks Rank #5 List
.
Zacks Names “Single Best Pick to Double”
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free report